Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Hypoglycemia

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cognitive flexibility subtypes and anorexia nervosa symptom severity: Evaluating the contribution of perfectionism.

Journal of psychiatric research·2026

Same author

Safety of very low LDL-cholesterol: Ten common concerns, misconceptions, and evidence-based clarifications.

Atherosclerosis·2026

Same author

Classification of Obesity Based on Weight History: Perceptions of People With Obesity.

Clinical obesity·2026

Same author

2025 Brazilian Evidence-based Guideline on the Management of Obesity and Prevention of Cardiovascular Disease and Obesity-Associated Complications: A Position Statement by Five Medical Societies.

Arquivos brasileiros de cardiologia·2025

Same author

Cycling Without Age Intervention: Effects on Loneliness, Social Isolation and Life Satisfaction of Older People.

Australasian journal on ageing·2025

Same author

Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries.

Liver international : official journal of the International Association for the Study of the Liver·2025

Search research articles

Related Experiment Video

Updated: May 28, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Depression, glycemic control and type 2 diabetes.

Marcelo Papelbaum¹, Rodrigo O Moreira, Walmir Coutinho

¹Obesity and Eating Disorders Group, Psychiatry Institute of the Federal University of Rio de Janeiro, Rio de Janeiro, 22290-140, Brazil. marcelo@papelbaum.com.

Diabetology & Metabolic Syndrome

|October 8, 2011

Summary

Major depression in type 2 diabetes mellitus (T2DM) patients is linked to poorer glycemic control. Individuals with depression showed higher glycated hemoglobin levels, indicating a significant impact on diabetes management.

More Related Videos

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Related Experiment Videos

Last Updated: May 28, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Area of Science:

Endocrinology
Psychiatry
Metabolic Disorders

Background:

Comorbid depression is a potential factor contributing to inadequate glycemic control in diabetes.
Understanding the link between major depression and type 2 diabetes mellitus (T2DM) is crucial for effective patient management.

Purpose of the Study:

To investigate the association between major depression and glycemic control in patients with T2DM.
To assess the impact of mood disorders on diabetes management outcomes.

Main Methods:

Seventy T2DM patients were psychiatrically evaluated using the Structured Clinical Interview for DSM-IV and Beck Depression Inventory.
Short-term glycemic control was assessed via glycemia and glycated hemoglobin (HbA1c) levels.

Main Results:

18.6% of T2DM patients (13/70) presented with current depression.
Depressed T2DM patients exhibited significantly higher glycated hemoglobin levels (8.6 ± 2.0%) compared to non-depressed patients (7.5 ± 1.8%; p = 0.05).

Conclusions:

Depression significantly impacts short-term glycemic control in T2DM patients.
Findings highlight the clinical importance of addressing depression in routine diabetes care.
Integrating mental health assessments can improve T2DM management and patient outcomes.